Arteaga-Henríquez, Gara http://orcid.org/0000-0002-1251-8988
Gisbert, Laura http://orcid.org/0000-0002-8329-1717
Ramos-Quiroga, Josep Antoni http://orcid.org/0000-0003-1622-0350
Article History
Accepted: 13 February 2023
First Online: 13 March 2023
Declarations
:
: No funding was secured for this study. Open access publication was supported by the Group of Psychiatry, Mental Health and Addiction of Vall d'Hebron Research Institute, Barcelona, Catalonia, Spain.
: All authors have no financial relationships to disclose relevant to this article. Josep Antoni Ramos-Quiroga was on the speakers’ bureau and/or acted as a consultant for Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogi, Sincrolab, Novartis, BMS, Medice, Rubió, Uriach, Technofarma and Raffo in the last 3 years, and also received travel awards (air tickets + hotel) from Janssen-Cilag, Rubió, Shire, Takeda, Shionogi, Bial and Medice for taking part in psychiatric meetings. The Department of Psychiatry chaired by Josep Antoni-Ramos-Quiroga received unrestricted educational and research support from Janssen-Cilag, Shire, Oryzon, Roche, Psious, and Rubió in the last 3 years.
: Data sharing was not applicable to this article as no datasets were generated and/or analyzed during the current study.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: GAH: conceptualization, data curation, investigation, methodology, validation, visualization, writing—original draft, review, and editing. LG: data curation, investigation, methodology, validation, visualization: review, and editing. JARQ: writing—review, and editing. All authors read and approved the final submitted manuscript and agree to be accountable for this work.